GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diagnosticos da America SA (BSP:DASA3) » Definitions » Altman Z-Score

Diagnosticos da America (BSP:DASA3) Altman Z-Score : 0.73 (As of Apr. 26, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Diagnosticos da America Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Warning Sign:

Altman Z-score of 0.72 is in distress zone. This implies bankruptcy possibility in the next two years.

Diagnosticos da America has a Altman Z-Score of 0.73, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Diagnosticos da America's Altman Z-Score or its related term are showing as below:

BSP:DASA3' s Altman Z-Score Range Over the Past 10 Years
Min: 0.72   Med: 2.14   Max: 2.81
Current: 0.72

During the past 13 years, Diagnosticos da America's highest Altman Z-Score was 2.81. The lowest was 0.72. And the median was 2.14.


Diagnosticos da America Altman Z-Score Historical Data

The historical data trend for Diagnosticos da America's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagnosticos da America Altman Z-Score Chart

Diagnosticos da America Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Altman Z-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.72 2.81 1.18 0.94 0.85

Diagnosticos da America Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.94 0.72 0.88 0.96 0.85

Competitive Comparison of Diagnosticos da America's Altman Z-Score

For the Diagnostics & Research subindustry, Diagnosticos da America's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diagnosticos da America's Altman Z-Score Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diagnosticos da America's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Diagnosticos da America's Altman Z-Score falls into.



Diagnosticos da America Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Diagnosticos da America's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.053+1.4*-0.0641+3.3*0.0303+0.6*0.1821+1.0*0.5437
=0.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2023:
Total Assets was R$26,213 Mil.
Total Current Assets was R$7,032 Mil.
Total Current Liabilities was R$5,641 Mil.
Retained Earnings was R$-1,680 Mil.
Pre-Tax Income was -408.206 + -129.201 + -229.707 + -228.838 = R$-996 Mil.
Interest Expense was -384.551 + -463.292 + -449.852 + -493.439 = R$-1,791 Mil.
Revenue was 3318.212 + 3769.014 + 3630.94 + 3534.07 = R$14,252 Mil.
Market Cap (Today) was R$3,437 Mil.
Total Liabilities was R$18,879 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(7031.514 - 5641.375)/26213.2
=0.053

X2=Retained Earnings/Total Assets
=-1679.779/26213.2
=-0.0641

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-995.952 - -1791.134)/26213.2
=0.0303

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=3437.077/18879.381
=0.1821

X5=Revenue/Total Assets
=14252.236/26213.2
=0.5437

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Diagnosticos da America has a Altman Z-Score of 0.73 indicating it is in Distress Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.


Diagnosticos da America  (BSP:DASA3) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Diagnosticos da America Altman Z-Score Related Terms

Thank you for viewing the detailed overview of Diagnosticos da America's Altman Z-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Diagnosticos da America (BSP:DASA3) Business Description

Traded in Other Exchanges
N/A
Address
Avenida Jurua, 434, Alphaville, Barueri, SP, BRA, 06455-010
Diagnosticos da America SA operates as a medical diagnostics company in Brazil. The company offers clinical analysis, diagnostic imaging tests, and patient service centers. It has three operating segments. Outpatient care services and care coordination includes Diagnosis and health management, Hospitals and oncology include Medical and hospital services & Foreign operations include Diagnosis. The majority is from the Hospitals and oncology segment. Geographically, it operates in Brazil and South America (Argentina, Uruguay, Chile and Colombia).

Diagnosticos da America (BSP:DASA3) Headlines

No Headlines